• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Arfolitixorin Lands FDA Fast Track Designation for Advanced CRC

    TARGETEDONC

    Isofol announces licensing agreement for Paladin Labs to arfolitixorin

    BIOSPACE

    Invitation to a conference call & webcast Isofol license agreement Paladin Labs

    PRNEWSWIRE

    ISOFOL ENTERS LICENSING AGREEMENT WITH SOLASIA COMMERCIALIZE ARFOLITIXORIN

    ISOFOLMEDICAL

    Isofol enters licensing agreement with Solasia to develop arfolitixorin in Japan

    PRNEWSWIRE

    Isofol`s Drug Candidate Arfolitixorin Receives Add Clinical Patent Approval

    PRNEWSWIRE

    The First Patient Included in Japan in Isofol`s Phase 3 AGENT Study

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.